Freudly+971 508685814hello@freudly.ai
Freudly

Paroxysmal Nocturnal Hemoglobinuria Quiz

Paroxysmal Nocturnal Hemoglobinuria Quiz - FreudlyTake a free paroxysmal nocturnal hemoglobinuria quiz to explore your paroxysmal nocturnal hemoglobinuria. Quick, no sign-up needed. Start now!en
With 15 questions and an estimated completion time of 10 minutes, this self-report tool explores experiences and known testing context relevant to this condition. The paroxysmal nocturnal hemoglobinuria quiz highlights blood-count, clot-warning, and hemolysis- or anemia-related topics, helping you organize concerns for a clinician and reflect on next steps.
Questions: 1510 minutes
Paroxysmal Nocturnal Hemoglobinuria Quiz: situation and reply bubbles
July 22, 2026July 22, 2026Material has been updatedJuly 22, 2026Material has been published
5,718 views
528 completions
454 likes
Daniel HallPsychologist · Test reviewer
454 likes
Scale Explorer

How the Scales are Structured

Blood Count and PNH Testing ContextBCaPTC
This scale summarizes reported blood-count findings and prior PNH-related testing context that may be relevant to discuss with a clinician.
example score5/15
5/15Prompt follow-up warrantedexample score
0No known indicators
1 – 2Context to review
3 – 15Prompt follow-up warranted
A score of 5 falls in the “Prompt follow-up warranted” range, indicating you selected multiple items suggesting prior blood-count or testing context that may merit timely clinical review.
Clot and Emergency Warning SignsCaEWS
Summarizes endorsement of clot-related and emergency warning-sign patterns that may warrant urgent clinical attention.
example score6/15
6/15Prompt action warrantedexample score
0No indicators endorsed
1 – 2Medical review appropriate
3 – 15Prompt action warranted
A score of 6 falls in the “Prompt action warranted” range, indicating multiple endorsed warning signs where any single concerning experience is important regardless of the total.
Hemolysis and Anemia-Related ChangesHaARC
This scale summarizes self-reported changes that can be consistent with hemolysis and anemia-related effects (e.g., fatigue, dark urine, low hemoglobin history).
example score10/15
10/15Prompt action warrantedexample score
0No indicators endorsed
1 – 2Worth discussing
3 – 15Prompt action warranted
A score of 10 falls in the “Prompt action warranted” range, indicating multiple hemolysis/anemia-related changes were endorsed and may be important to discuss promptly in a clinical context.
just completed the test
DATA-BASED USER COHORTS

Who Usually Takes This Test?

Unexplained anemia symptoms
41%OF USERS
People with ongoing fatigue, pale skin, shortness of breath, or dark urine who want to see whether their symptom pattern could be worth discussing with a clinician.
Clot concern after warning signs
34%OF USERS
People who have had a blood clot, unusual abdominal or chest pain episodes, or other clot warning signs and want to organize what happened before talking to a healthcare professional.
Abnormal blood test history
25%OF USERS
People with persistent abnormal CBC results like low hemoglobin, low platelets, or low white cells who want to gather details to bring to a medical appointment.
BASED ON AGGREGATED, ANONYMIZED DATA FROM TENS OF THOUSANDS OF FREUDLY USERS.
Benchmarking

See How You Compare

Once you complete the test, your results are compared with real-world data from people in your country.
Below is a preview of how scores are typically distributed across each scale.
Shaded area — where most people score
Dot — the average
You — your score lands on each curve after the test— your score, after the test
Blood Count and PNH Testing ContextBCaPTC
You?
Average6.9
Typical rangeTypical4.2 – 9.5
Possible0 – 15
Clot and Emergency Warning SignsCaEWS
You?
Average6.4
Typical rangeTypical3.8 – 8.9
Possible0 – 15
Hemolysis and Anemia-Related ChangesHaAC
You?
Average9.8
Typical rangeTypical7.3 – 12.3
Possible0 – 15
Featured On
SAMPLE QUESTIONS

Example Questions From the Test

    • My tested results have not shown hemolysis.
    • One result was borderline or temporarily abnormal, without a continuing pattern.
    • Repeated results have suggested hemolysis, such as abnormal LDH, bilirubin, haptoglobin, or reticulocytes.
    • A clinician identified active intravascular hemolysis requiring prompt investigation, monitoring, or treatment.
    • I have not been diagnosed with or evaluated for a bone-marrow failure disorder.
    • A clinician considered a marrow problem, but no such disorder was diagnosed.
    • I have a diagnosed marrow condition other than aplastic anemia, such as a myelodysplastic disorder.
    • I have been diagnosed with aplastic anemia or another significant bone-marrow failure syndrome.
    • None of these chest or breathing experiences.
    • Brief mild discomfort or breathlessness that settled promptly and has not returned.
    • Recurring breathlessness or sharp chest discomfort, particularly when taking a breath.
    • Sudden chest pain, severe breathing difficulty, coughing blood, blue lips, or fainting.
WHAT THE TEST MEASURES

Paroxysmal Nocturnal Hemoglobinuria Quiz - Description and methodology of the test

People considering evaluation for unexplained anemia, dark urine, unusual fatigue, clot-related symptoms, or a possible PNH history may find the paroxysmal nocturnal hemoglobinuria quiz useful when deciding what to discuss with a clinician. This online self-report questionnaire organizes reported experiences, known findings, and testing context; it is not a PNH test that interprets laboratory values or establishes a diagnosis. That structure supports a more focused decision about what to do next.

What This Assessment Explores

The questions connect PNH-related medical context with dark urine, jaundice, fatigue, breathlessness, low counts, clot history, marrow disorders, and flow-cytometry testing.

The result presents three result summaries; this questionnaire helps organize reported experiences and known findings before a paroxysmal nocturnal hemoglobinuria test or clinical conversation:

  • Blood Count and PNH Testing Context (0-15) summarizes blood-count, marrow, and flow-cytometry context; bands are No known indicators (0), Context to review (1-2), and Prompt follow-up warranted (3-15).
  • Clot and Emergency Warning Signs (0-15) reflects clot history and urgent chest, breathing, abdominal, limb, or neurological patterns; bands are No indicators endorsed (0), Medical review appropriate (1-2), and Prompt action warranted (3-15).
  • Hemolysis and Anemia-Related Changes (0-15) reflects dark urine, yellowing, weakness, breathlessness, low counts, and anemia treatment; bands are No indicators endorsed (0), Worth discussing (1-2), and Prompt action warranted (3-15).

Methodology and Scientific Basis

Each question offers four ordered choices, moving from no known concern or a mild, isolated experience toward repeated findings, confirmed history, severe impairment, or an emergency pattern. The structure summarizes the respondent’s described concern without assigning laboratory values or inferring a diagnosis.

In its online self-report format, the PNH quiz uses displayed summaries that are unvalidated reflective and safety measures, not standardized clinical scales. The result instructions state that a single red-flag 3-point response overrides the total, so a reassuring aggregate should not outweigh that response.

The Richards et al. (2020) study provides the closest clinical context, describing a patient cohort whose GPI-deficient cells were detected by flow cytometry. Parker et al. (2005) supports discussion of hemolysis, thrombosis, marrow failure, and diagnostic management, while Borowitz et al. (2010) provides flow-cytometry guidance for diagnosis and monitoring. The questionnaire is conceptually consistent with these sources, not an adaptation or validated reproduction of their instruments.

Interpretation should consider timing, confirmed results, and current health context. Recall, self-awareness, and response style can affect self-report, while bands organize follow-up attention rather than clinical severity.

Literature:
  • Richards SJ, Dickinson AJ, Cullen MJ, Griffin M, Munir T, McKinley C, Mitchell LD, Newton DJ, Arnold L, Hill A, Hillmen P. Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry. British Journal of Haematology. 2020;189(5):954-966. 10.1111/bjh.16427
  • Parker C, Omine M, Richards S, Nishimura JI, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Socie G, International PNH Interest Group. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106(12):3699-3709. 10.1182/blood-2005-04-1717
  • Borowitz MJ, Craig FE, DiGiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR, Wittwer CT, Richards SJ, Clinical Cytometry Society. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry Part B: Clinical Cytometry. 2010;78(4):211-230. 10.1002/cyto.b.20525
Popular tests
Comments
Leave a Comment